CAS 1000676-41-4

Lirilumab

CAS: 1000676-41-4

Reinheit: 98%

Ref: IN-DA027G8I

Lirilumab

CAS: 1000676-41-4

Lirilumab (IPH2102) is an antibody against the lethal immunoglobulin-like receptor antibody KIR2D with antitumor activity that enhances the anti-HPV + cervical

Reinheit: 98.4% (SEC-HPLC) - >95.0% (SDS-PAGE)

Farbe und Form: Liquid

Molekulargewicht: 145.52 kDa

Ref: TM-T77423